Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Public ClinicalTrials.gov record NCT01571297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effects of RM-131 on gastric emptying, gastroparesis symptoms, and the safety and tolerability of RM-131 compared to placebo in patients with Type 1 and Type 2 diabetes mellitus and gastroparesis. The study is designed to evaluate the efficacy and safety of multiple dose regimens of RM-131. Study drug (RM-131 and placebo) will be administered subcutaneously in a blinded fashion.
Study identification
- NCT ID
- NCT01571297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 204 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2012 (Type not available)
- Primary completion
- Aug 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Sep 23, 2016
2012 – 2013
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Dothan | Alabama | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | North Little Rock | Arkansas | — | — |
| Not listed | Concord | California | — | — |
| Not listed | Lomita | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Inverness | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Monroe | Louisiana | — | — |
| Not listed | Chevy Chase | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Farmington Hills | Michigan | — | — |
| Not listed | Jackson | Mississippi | — | — |
| Not listed | Lebanon | New Hampshire | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Germantown | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01571297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2016 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01571297 live on ClinicalTrials.gov.